The flow cytometry market is expanding due to increased investment in immuno-oncology and liquid biopsy sectors. With advancements in genome-based research and single-cell analysis, flow cytometry ...
Urbanization and a warmer climate means that more people want to swim in canals, harbors, and urban beaches. However, this ...
Global Hematology Market OverviewThe global hematology market is projected to grow at a CAGR of approximately 3–5% through ...
A new Swedish innovation uses machine learning and laser scanning to identify contaminated water in just 20 minutes, reducing ...
According to research by SNS Insider, the U.S. Cell Analysis Market is projected to grow at a CAGR of 9.77%, Fueled by strong biotechnology capabilities, expanding precision medicine initiatives & ...
Urbanisation and a warmer climate means that more people want to swim in canals, harbours, and urban beaches. However, this means that they may swimming close to where treated wastewater and ...
BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...
A laser-based testing approach created by researchers at Lund University, Sweden Water Research, and Kristianstad University has been successfully tested in Helsingborg, where the test turnaround time ...
The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted ...
The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...
At ELRIG 2025 in Stevenage, AstraZeneca’s Global Leader for Flow Cytometry, Dr Raffaello Cimbro, outlined how imaging flow ...
Minimal residual disease is “a credible intermediate endpoint” for some patients with newly diagnosed acute myeloid leukemia, researchers report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback